Close
Smartlab Europe
Achema middle east

content

Medigene strengthens its patent portfolio with a European patent covering T cell identification method

Medigene AG , a clinical stage immune-oncology company focusing on the development of T cell immuno-therapies for the treatment of cancer, announces the grant...

International symposium on microencapsulation

Together with the Bioactives World Forum, the contract manufacturer SternMaid will be organizing an international symposium on the subject of microencapsulation in Hamburg on...

Recipharm and Altus Formulation collaborate to offer novel drug delivery technologies for value added medicines

Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug development company, to allow...

Lilly’s Verzenio for Advanced Breast Cancer Receives Additional FDA Approval

Eli Lilly and Company announced that the U.S. FDA has approved Verzenio™ in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for...

Haverford Trust Co. elevated its position in shares of Eli Lilly and Co by 16.3%

Haverford Trust Co. lifted its position in shares of Eli Lilly and Co by 16.3% during the fourth quarter, according to the company in...

Novo Nordisk records for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A

Novo Nordisk announced the submission of a Biologics License Applications (BLA) to the US FDA and a Marketing Authorisation Application (MAA) to the European...

Johnson & Johnson Human Performance Institute Invests $18 Million for future of Lake Nona Medical City

The Johnson & Johnson Human Performance Institute today announced it is expanding its footprint in the Lake Nona community in Orlando, Florida with the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »